Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04513782 · ClinicalTrials.gov registry record

The Contributions of Age Related Changes in the Sound Localization Pathway to Central Hearing Loss

A clinical trial of Healthy Individuals and Hearing Loss, Central, sponsored by University of Colorado, Denver.

Recruiting
Registry status
200
Enrollment target
1
Study location

NCT04513782: Recruiting study of Healthy Individuals and Hearing Loss, Central, sponsored by University of Colorado, Denver.

NCT04513782 is a study of Healthy Individuals and Hearing Loss, Central that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 200 participants, above the 58-participant average among 3 other Healthy Individuals trials with a reported enrollment target (245% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04513782, a study of Healthy Individuals and Hearing Loss, Central, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
200 participants
Enrollment target
1
Study location

Study Summary

Age-related hearing loss, presbycusis, affects up to 50% of American adults. There are two main causes for presbycusis: 1) Progressive death of hair cells in the inner ear, and 2) Central hearing loss, or the reduced ability to decipher the sound source of interest from other competing sounds in a multi-source complex environment. The first cause is better understood and treatment options, such as hearing aids and cochlear implants, are available. However, central hearing loss is not as well understood and there is not a treatment available at this time. This study aims to advance our understanding of central hearing loss by evaluating the abilities of younger and older listeners in two primary outcome measures: to 1) neurologically process sound stimuli and 2) focus on conversational speech in the presence of spatially-separated competing background noise. A test using Auditory Brainstem Responses (ABR) will be used to evaluate the brain's response to clicking sounds. This study will assess all waveform data, but will focus particularly on wave III. Sentence in noise tests will be used to assess each subject's ability to process speech in noisy situations. Both the ABR and sentence in noise tests are non-invasive and are commonly used in audiology practices to diagnosis and treat a variety of audiological pathologies.

Interventions

  • DIAGNOSTIC_TEST Audiological Assessments

Study Locations (1)

Colorado

  • University of Colorado School of Medicine - Aurora

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2020-10-01
Est. Completion 2026-05-29
University of Colorado, Denver

1,283 total trials

What NCT04513782 shows while recruiting

NCT04513782 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 58-participant average among 3 other Healthy Individuals trials with a reported enrollment target (245% higher).

The record links to 2 conditions, with Healthy Individuals appearing as the primary indexed condition, and to 1 intervention - of which Audiological Assessments is the first listed.

NCT04513782 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT04513782 about?

NCT04513782 is a clinical study titled "The Contributions of Age Related Changes in the Sound Localization Pathway to Central Hearing Loss". Age-related hearing loss, presbycusis, affects up to 50% of American adults. There are two main causes for presbycusis: 1) Progressive death of hair cells in the inner ear, and 2) Central hearing loss, or the reduced ability to decipher the sound source of interest from other competing sounds in a m...

What is the current status of trial NCT04513782?

This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2020-10-01. Estimated completion is 2026-05-29.

What conditions does trial NCT04513782 study?

This clinical trial studies the following conditions: Healthy Individuals, Hearing Loss, Central.

What interventions are being tested in trial NCT04513782?

The interventions under investigation include: Audiological Assessments (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04513782?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04513782 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Individuals

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04513782, the US trial registry maintained by the National Library of Medicine. NCT04513782 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.